Brief: NW Bio Moves Forward With SEC Settlement
10/10/2019 22:46
Oct 10 (Reuters) - Northwest Biotherapeutics Inc NWBO.PK :
* NW BIO MOVES FORWARD WITH SEC SETTLEMENT
* NORTHWEST BIOTHERAPEUTICS INC - WILL PAY A FINE OF
$250,000 IN
CONNECTION WITH PAST WEAKNESSES IN ITS INTERNAL CONTROLS
Source text for Eikon: ID:nPn4jrCHsa
Further company coverage: NWBO.PK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB